https://kstockbriefing.com
Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary SK Hynix has decided to list American Depositary Receipts (ADRs) on the U.S. Nasdaq Global Select Market by issuing 177,900,000 ADRs based on 17,790,000 new common shares to expand its global investor base. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up…
![[Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Tangible Assets / 2026-06-24](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화시스템.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems decided to acquire land and buildings of ‘Hanwha Future Technology Research Institute’ located in Seongnam-si, Gyeonggi-do from Hanwha Corporation for KRW 287.85B for management purposes, representing 2.79% of its recent total consolidated assets. 📊 Key Disclosure Contents & Financial Figures 📝 Editor’s Comment (Key…
Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO announced that Korea Hydro & Nuclear Power withdrew its arbitration case at the London Court of International Arbitration following a mutual agreement to transfer the venue to the Korean Commercial Arbitration Board. 📊 Key Disclosure Content & Financial Highlights • Disclosure Title:…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has expanded a contract manufacturing agreement originally signed in August 2018, increasing the value from KRW 144.6B to KRW 215.9B upon the client’s request and extending the contract term through 2037. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…
![[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2026-06-22](https://kstockbriefing.com/wp-content/uploads/2026/07/포맷변환-한미반도체-1.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor is attending the ‘2026 CITIC CLSA Northeast Asia Forum’ to host an IR event for key overseas institutional investors, presenting its AI system semiconductor market entry, new TC bonder launches, and U.S. expansion plans. 📊 [Summary of Key Disclosure Content and Major Figures] 📝…
![[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-06-19](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환한화오션.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has filed a correction disclosure regarding its contract for 4 Very Large Crude Carriers (VLCCs) worth approximately KRW 800.1B (6.3% of revenue) with an Asian shipowner, updating the contract start date following the agreement becoming effective on June 19, 2026. 📊 [Key Disclosure Details…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion’s Part 1 approval for the European Phase 3 trial of CT-P13 SC in pediatric ulcerative colitis has expired under EU CTR regulations as the company opted not to submit a Part 2 application due to a change in development strategy. 📊 [Key Disclosure Details &…
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion’s Part 1 approval for the European Phase 3 trial of CT-P13 SC in pediatric Crohn’s disease has expired under EU CTR regulations as the company opted not to submit a Part 2 application due to a change in development strategy. 📊 [Key Disclosure Details &…
![[Disclosure] Hyundai Motor (005380) – Investor Relations(IR) Schedule / 2026-06-18](https://kstockbriefing.com/wp-content/uploads/2026/08/포맷변환-현대차.jpg)
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor has disclosed that it will participate in an IR conference sponsored by CLSA from June 23 to June 24, 2026, at the Conrad Seoul Hotel, hosting one-on-one and small group meetings for institutional investors. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment…
Read More “[Disclosure] Hyundai Motor (005380) – Investor Relations(IR) Schedule / 2026-06-18” »
Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has expanded a contract manufacturing agreement originally signed in April 2025, increasing the value from KRW 737.3B to KRW 835.7B upon the client’s request. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Future Amended Disclosures Regarding Changes in…